Factors Affecting the Price of Agamree

AGAMREE is administered as an oral suspension (40 mg/mL), taken once daily with food to enhance absorption. Unique to its class, it allows direct switching from other corticosteroids (e.g., prednisone) without dose tapering, reducing adrenal crisis risk. Dosing flexibility accommodates hepatic impairment and drug interactions (e.g., strong CYP3A4 inhibitors). 

Key warnings include immunosuppression, endocrine dysfunction, and behavioral disturbances. Long-term effects on growth, bone density, and cardiac outcomes remain under surveillance, with no geriatric data available due to DMD’s pediatric predominance. Clinical response is monitored via functional assessments and metabolic parameters, aligning with DMD management guidelines.